Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.
Int J Chron Obstruct Pulmon Dis
; 12: 339-349, 2017.
Article
in En
| MEDLINE
| ID: mdl-28176893
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bronchodilator Agents
/
Quinolones
/
Muscarinic Antagonists
/
Pulmonary Disease, Chronic Obstructive
/
Asian People
/
Adrenergic beta-2 Receptor Agonists
/
Fluticasone-Salmeterol Drug Combination
/
Glycopyrrolate
/
Indans
/
Lung
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Int J Chron Obstruct Pulmon Dis
Year:
2017
Document type:
Article
Affiliation country:
Reino Unido
Country of publication:
Nueva Zelanda